Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death

Eran Schmukler1, Eya Wolfson, Roni Haklai

  • 1Department of Neurobiology. Tel-Aviv University, Ramat-Aviv, Israel.

Oncotarget
|December 26, 2013
PubMed

Insights

Combining FTS with chloroquine, an autophagy inhibitor, synergistically reduces cancer cell viability and enhances apoptosis. This combination therapy shows promise for cancer treatment by overcoming FTS-induced autophagy-mediated protection.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Ras signaling is crucial for cell growth and survival, and its aberrant activation drives many human cancers.
  • Ras signaling influences autophagy, a cellular degradation process that can impact cancer cell survival and drug resistance.
  • FTS, a Ras inhibitor, induces autophagy, which may limit its efficacy as an anti-cancer drug.

Purpose of the Study:

  • To investigate the synergistic effects of FTS and chloroquine (an autophagy inhibitor) on cancer cell growth and death.
  • To elucidate the underlying mechanisms of FTS and chloroquine's combined action in cancer cells.

Main Methods:

  • Treatment of HCT-116 and Panc-1 cancer cells with FTS and chloroquine, individually and in combination.
  • Assessment of autophagy induction and inhibition.
  • Evaluation of cell viability, apoptosis markers (sub-G1 population, Hoechst staining, caspase 3 activation, survivin expression, cytochrome c release).

Main Results:

  • FTS treatment induced autophagy in cancer cells, which was effectively inhibited by chloroquine.
  • Combined FTS and chloroquine treatment synergistically decreased cancer cell viability.
  • The combination therapy significantly enhanced apoptotic cell death, evidenced by increased caspase 3 activation and cytochrome c release, and decreased survivin expression.

Conclusions:

  • Chloroquine can overcome FTS-induced autophagy-mediated cancer cell protection.
  • The combination of FTS and chloroquine demonstrates synergistic anti-cancer effects, promoting apoptosis and inhibiting tumor cell growth.
  • This combination strategy holds potential for improving cancer therapy outcomes.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K